Inari Medical, Inc. (NARI)

Sector:
HEALTH CARE
Industry:
HEALTH CARE SUPPLIES
SIC:
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
CEO:
William H. Hoffman
Employees:
800
9 PARKER, SUITE 100, IRVINE, CA 92618
949-923-4747

Inari Medical, Inc. develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels. FlowTriever 2, a new disk shape designed to capture and remove wall adherent clot and shorten treatment.

Data derived from most recent annual or quarterly report
Market Cap 3.812 Billion Shares Outstanding57.172 Million Avg 30-day Volume 516.44 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.19
Price to Revenue7.7445 Debt to Equity0.0 EBITDA-21.595 Million
Price to Book Value7.8068 Operating Margin-5.132 Enterprise Value3.063 Billion
Current Ratio7.635 EPS Growth-0.111 Quick Ratio6.88
1 Yr BETA 1.0044 52-week High/Low 83.84 / 52.59 Profit Margin-3.6626
Operating Cash Flow Growth316.4054 Free Cash Flow to Firm (FCFF) TTM -30.606 Million Free Cash Flow to Equity (FCFE) TTM-22.056 Million
Altman Z-Score24.2992
Earnings Report2023-11-01
View SEC Filings from NARI instead.

View recent insider trading info

Inari Medical, Inc. YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding NARI (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding NARI

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2023-09-14 by HILL, MITCH C.
  • 4: filed on 2023-08-18 by HYKES ANDREW
  • 4: filed on 2023-08-18 by TU THOMAS
  • 4: filed on 2023-08-16 by HILL, MITCH C.
  • 4: filed on 2023-07-14 by HILL, MITCH C.
  • 4: filed on 2023-07-05 by HYKES ANDREW
  • 4: filed on 2023-07-05 by HILL, MITCH C.
  • 4: filed on 2023-07-05 by TU THOMAS
  • 4: filed on 2023-06-16 by HOFFMAN WILLIAM
  • 4: filed on 2023-06-13 by HILL, MITCH C.

    • Events (8k)

  • 8-K: filed on 2023-09-22:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-08-02:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-05-19:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2023-05-03:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-01-27:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-01-10:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-12-19:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-11-02:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-09-20:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-08-03:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits

    • Proposed Sales (Form 144)

  • 144: filed on 2023-09-15:
  • 144: filed on 2023-08-15:
  • 144: filed on 2023-07-17:
  • 144: filed on 2023-05-18:
  • 144: filed on 2023-05-18:
  • 144: filed on 2023-05-18:
  • 144: filed on 2023-05-15:
  • 144: filed on 2023-04-17:
  • 144: filed on 2023-06-12:
  • 144: filed on 2023-08-14:

    • Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    124.6 Thousand total shares from 27 transactions

    Exercise Derivative Conversion (M)

    13 Thousand total shares from 2 transactions

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    HOFFMAN WILLIAM

    • Director
    		 1,023,055 2023-09-15 17

    HILL, MITCH C. CHIEF FINANCIAL OFFICER

    • Officer
    		 173,402 2023-09-12 17

    TU THOMAS CHIEF MEDICAL OFFICER

    • Officer
    		 347,997 2023-08-16 13

    HYKES ANDREW PRESIDENT AND CEO

    • Officer
    • Director
    		 477,682 2023-08-16 13

    ROOT JONATHAN D

    • Director
    		 537,358 2023-05-27 2

    MILDER DONALD B

    • Director
    		 3,230,614 2023-05-27 5

    NIELSEN KIRK G.

    • Director
    		 61,479 2023-05-27 2

    MEAD DANA G JR.

    • Director
    		 7,022 2023-05-18 1

    LUCCHESE CYNTHIA L

    • Director
    		 34,303 2023-05-18 1

    SZYMAN CATHERINE M.

    • Director
    		 18,303 2023-05-18 2

    CHAMBERS REBECCA

    • Director
    		 6,782 2023-05-18 1

    WARNER ROBERT KEITH

    • Director
    		 8,023 2023-05-18 1

    PRESIDIO MANAGEMENT GROUP X LLC

    US VENTURE PARTNERS X LP

    USVP X AFFILIATES LP

    TANSEY CASEY M

    • 10% Owner
    		 No longer subject to file 2021-03-16 0

    COOPERATIEVE GILDE HEALTHCARE IV U.A.

    GILDE HEALTHCARE IV MANAGEMENT B.V.

    GILDE HEALTHCARE HOLDING B.V.

    • 10% Owner
    		 No longer subject to file 2021-03-12 0

    PRESIDIO MANAGEMENT GROUP X LLC

    US VENTURE PARTNERS X LP

    USVP X AFFILIATES LP

    FEDERMAN IRWIN

    KRAUSZ STEVEN M

    LEWIS RICHARD W.

    MATTEUCCI PAUL A

    TANSEY CASEY M

    • 10% Owner
    		 5,751,254 2020-11-17 0

    VERSANT VENTURES IV, LLC

    VERSANT VENTURE CAPITAL IV, L.P.

    VERSANT SIDE FUND IV, L.P.

    • 10% Owner
    		 No longer subject to file 2020-11-17 0

    PRESIDIO MANAGEMENT GROUP X LLC

    TANSEY CASEY M

    • 10% Owner
    		 165,692 2020-11-17 0

    PARDO GEOFFREY B

    • Director
    		 0 2020-05-27 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    HOFFMAN WILLIAM - Director

    		2023-09-19 16:38:10 -0400 2023-09-15 S 7,901 $67.05 d 1,033,055 direct yes -1.3709 -0.3164 0.0 1 -4.2633 3

    HOFFMAN WILLIAM - Director

    		2023-09-19 16:38:10 -0400 2023-09-15 S 7,099 $66.40 d 1,040,956 direct yes -1.3709 -0.3164 0.0 1 -4.2633 3

    HOFFMAN WILLIAM - Director

    		2023-09-19 16:38:10 -0400 2023-09-15 S 6,671 $66.95 d 1,023,155 direct yes -1.3709 -0.3164 0.0 1 -4.2633 3

    HOFFMAN WILLIAM - Director

    		2023-09-19 16:38:10 -0400 2023-09-15 S 3,229 $66.27 d 1,029,826 direct yes -1.3709 -0.3164 0.0 1 -4.2633 3

    HOFFMAN WILLIAM - Director

    		2023-09-19 16:38:10 -0400 2023-09-15 S 100 $67.58 d 1,023,055 direct yes -1.3709 -0.3164 0.0 1 -4.2633 3

    HILL, MITCH C. - Officer CHIEF FINANCIAL OFFICER

    		2023-09-14 16:41:48 -0400 2023-09-12 M 6,500 d 113,977 direct yes

    HILL, MITCH C. - Officer CHIEF FINANCIAL OFFICER

    		2023-09-14 16:41:48 -0400 2023-09-12 M 6,500 $0.46 a 178,302 direct yes -0.7364 -4.4935 0.6011 3 -4.4935 6

    HILL, MITCH C. - Officer CHIEF FINANCIAL OFFICER

    		2023-09-14 16:41:48 -0400 2023-09-12 S 3,325 $68.35 d 171,802 direct yes -0.7364 -4.4935 0.6011 3 -4.4935 6

    HILL, MITCH C. - Officer CHIEF FINANCIAL OFFICER

    		2023-09-14 16:41:48 -0400 2023-09-12 S 2,120 $67.70 d 175,127 direct yes -0.7364 -4.4935 0.6011 3 -4.4935 6

    HILL, MITCH C. - Officer CHIEF FINANCIAL OFFICER

    		2023-09-14 16:41:48 -0400 2023-09-12 S 1,055 $66.59 d 177,247 direct yes -0.7364 -4.4935 0.6011 3 -4.4935 6

    TU THOMAS - Officer CHIEF MEDICAL OFFICER

    		2023-08-18 17:01:16 -0400 2023-08-16 S 6,732 $67.31 d 348,402 direct 1.7151 0.8962 3.8628 3 0.0 1

    HYKES ANDREW - Director - Officer PRESIDENT AND CEO

    		2023-08-18 17:05:02 -0400 2023-08-16 S 18,166 $65.31 d 493,642 direct 1.7151 0.8962 3.8628 3 0.0 1

    HYKES ANDREW - Director - Officer PRESIDENT AND CEO

    		2023-08-18 17:05:02 -0400 2023-08-16 S 9,906 $67.31 d 475,727 direct 1.7151 0.8962 3.8628 3 0.0 1

    HYKES ANDREW - Director - Officer PRESIDENT AND CEO

    		2023-08-18 17:05:02 -0400 2023-08-16 S 8,009 $66.32 d 485,633 direct 1.7151 0.8962 3.8628 3 0.0 1

    HYKES ANDREW - Director - Officer PRESIDENT AND CEO

    		2023-08-18 17:05:02 -0400 2023-08-16 S 595 $68.03 d 475,132 direct 1.7151 0.8962 3.8628 3 0.0 1

    TU THOMAS - Officer CHIEF MEDICAL OFFICER

    		2023-08-18 17:01:16 -0400 2023-08-16 S 12,346 $65.31 d 360,577 direct 1.7151 0.8962 3.8628 3 0.0 1

    TU THOMAS - Officer CHIEF MEDICAL OFFICER

    		2023-08-18 17:01:16 -0400 2023-08-16 S 5,443 $66.32 d 355,134 direct 1.7151 0.8962 3.8628 3 0.0 1

    TU THOMAS - Officer CHIEF MEDICAL OFFICER

    		2023-08-18 17:01:16 -0400 2023-08-16 S 405 $68.03 d 347,997 direct 1.7151 0.8962 3.8628 3 0.0 1

    HOFFMAN WILLIAM - Director

    		2023-08-17 16:46:32 -0400 2023-08-15 S 8,964 $68.61 d 1,064,091 direct yes 0.7158 2.5366 4.6063 4 0.0 1

    HOFFMAN WILLIAM - Director

    		2023-08-17 16:46:32 -0400 2023-08-15 S 6,192 $68.66 d 1,051,863 direct yes 0.7158 2.5366 4.6063 4 0.0 1

    HOFFMAN WILLIAM - Director

    		2023-08-17 16:46:32 -0400 2023-08-15 S 5,636 $69.52 d 1,058,455 direct yes 0.7158 2.5366 4.6063 4 0.0 1

    HOFFMAN WILLIAM - Director

    		2023-08-17 16:46:32 -0400 2023-08-15 S 3,508 $69.53 d 1,048,355 direct yes 0.7158 2.5366 4.6063 4 0.0 1

    HOFFMAN WILLIAM - Director

    		2023-08-17 16:46:32 -0400 2023-08-15 S 400 $70.93 d 1,058,055 direct yes 0.7158 2.5366 4.6063 4 0.0 1

    HOFFMAN WILLIAM - Director

    		2023-08-17 16:46:32 -0400 2023-08-15 S 300 $70.92 d 1,048,055 direct yes 0.7158 2.5366 4.6063 4 0.0 1

    HILL, MITCH C. - Officer CHIEF FINANCIAL OFFICER

    		2023-08-16 16:46:39 -0400 2023-08-14 S 640 $70.17 d 175,566 direct yes -0.2019 2.05 4.3951 5 -0.2019 2

    HILL, MITCH C. - Officer CHIEF FINANCIAL OFFICER

    		2023-08-16 16:46:39 -0400 2023-08-14 M 6,500 d 120,477 direct yes

    HILL, MITCH C. - Officer CHIEF FINANCIAL OFFICER

    		2023-08-16 16:46:39 -0400 2023-08-14 M 6,500 $0.46 a 178,302 direct yes -0.2019 2.05 4.3951 5 -0.2019 2

    HILL, MITCH C. - Officer CHIEF FINANCIAL OFFICER

    		2023-08-16 16:46:39 -0400 2023-08-14 S 2,397 $71.66 d 173,169 direct yes -0.2019 2.05 4.3951 5 -0.2019 2

    HILL, MITCH C. - Officer CHIEF FINANCIAL OFFICER

    		2023-08-16 16:46:39 -0400 2023-08-14 S 1,367 $71.71 d 171,802 direct yes -0.2019 2.05 4.3951 5 -0.2019 2

    HILL, MITCH C. - Officer CHIEF FINANCIAL OFFICER

    		2023-08-16 16:46:39 -0400 2023-08-14 S 1,187 $68.92 d 176,206 direct yes -0.2019 2.05 4.3951 5 -0.2019 2

    HILL, MITCH C. - Officer CHIEF FINANCIAL OFFICER

    		2023-08-16 16:46:39 -0400 2023-08-14 S 909 $67.70 d 177,393 direct yes -0.2019 2.05 4.3951 5 -0.2019 2

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    INARI MEDICAL INC NARI 2023-09-29 22:15:03 UTC 5.07 0.25 600000
    INARI MEDICAL INC NARI 2023-09-29 21:45:04 UTC 5.07 0.25 600000
    INARI MEDICAL INC NARI 2023-09-29 21:15:03 UTC 5.07 0.25 600000
    INARI MEDICAL INC NARI 2023-09-29 20:45:05 UTC 5.07 0.25 600000
    INARI MEDICAL INC NARI 2023-09-29 20:15:04 UTC 5.07 0.25 600000
    INARI MEDICAL INC NARI 2023-09-29 19:45:04 UTC 5.07 0.25 600000
    INARI MEDICAL INC NARI 2023-09-29 19:15:03 UTC 0.0 0.0 600000
    INARI MEDICAL INC NARI 2023-09-29 18:45:03 UTC 0.0 0.0 600000
    INARI MEDICAL INC NARI 2023-09-29 18:15:03 UTC 0.0 0.0 600000
    INARI MEDICAL INC NARI 2023-09-29 17:45:03 UTC 5.07 0.25 600000
    INARI MEDICAL INC NARI 2023-09-29 17:15:04 UTC 5.07 0.25 600000
    INARI MEDICAL INC NARI 2023-09-29 16:45:04 UTC 5.07 0.25 600000
    INARI MEDICAL INC NARI 2023-09-29 16:15:03 UTC 5.07 0.25 600000
    INARI MEDICAL INC NARI 2023-09-29 15:45:04 UTC 5.07 0.25 600000
    INARI MEDICAL INC NARI 2023-09-29 15:15:04 UTC 5.07 0.25 600000
    INARI MEDICAL INC NARI 2023-09-29 14:45:04 UTC 5.07 0.25 600000
    INARI MEDICAL INC NARI 2023-09-29 14:15:04 UTC 5.07 0.25 600000
    INARI MEDICAL INC NARI 2023-09-29 13:45:03 UTC 5.07 0.25 600000
    INARI MEDICAL INC NARI 2023-09-29 13:15:04 UTC 5.07 0.25 600000
    INARI MEDICAL INC NARI 2023-09-29 12:45:05 UTC 5.07 0.25 600000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    Advanced Series Trust- AST QMA U.S. Equity Alpha Portfolio NARI -11100.0 shares, $-900210.0 2021-09-30 N-PORT
    Trust for Professional Managers- Convergence Long/Short Equity Fund NARI -761.0 shares, $-62812.94 2021-11-30 N-PORT
    Federated Hermes Adviser Series- Federated Hermes MDT Market Neutral Fund NARI -25130.0 shares, $-1461058.2 2023-06-30 N-PORT
    AQR Funds- AQR Alternative Risk Premia Fund NARI -4001.0 shares, $-232618.14 2023-06-30 N-PORT

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    WhaleWisdom Logo

    Elevate your investments